Keep up to date on the latest medical news at MDLinx - FREE!


  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

What are Rheumatologists Really Doing Online

  
  
  
  
  

What are Rheumatologists Really Doing Online? We know, and we want to tell you.

Did you know that M3 MDLinx is the leading digital provider of clinical news and information to over 85% of all US Rheumatologists?.

Did you know that M3 MDLinx is the leading digital provider of clinical news and information to over 85% of all US Rheumatologists?

Did you know that majority of Rheumatologists actually spend more time online engaged in activities that support care for their patients than on seeking information about new medical advances in their field? Did you think the two were the same? According to Rheumatologists, they aren't.

spending their time on and offline, and what matters most to them. We surveyed over 100 Rheumatologists in the United States, who see at least 200 patients per month, and discovered not just how doctors are communicating with pharma companies, their peers and their patients, but much more. We asked them:

  • How do you want pharma and biotech companies to communicate with you in comparison to how they communicate with you today?
  • Do your pharma and biotech reps provide you with the tools and knowledge you need to best do your job? What can they do better?
  • How often and through what outlets do you interact online for research, news, social, and informational purposes?
  • How often, in what forms and for what reason do you use technology most? How can pharma brands better utilize technology?
  • If you want a basic study with stock answers that vary slightly from year to year, you shouldn't call us. But if you want the inside scoop on what Rheumatologists really want and need, and insight on how they get information and how they share it, you should contact us today.

To learn more about the details of The CompleteRheumatologist Study or purchase the report, contact MDLinx marketing@mdlinx.com to learn more.

Contact: marketing@mdlinx.com

Tags: 

Serum B-cell activating factor assessment in a population of Egyptian patients with systemic sclerosis

  
  
  
  
  
International Journal of Rheumatic Diseases, 12/19/2012


Abdo MS et al. – To assess serum B–cell activating factor (BAFF) levels in patients with systemic sclerosis and to correlate this with disease features and disease severity. Serum BAFF levels were significantly elevated in patients with systemic sclerosis irrespective of disease subtype, disease duration or age of patients. This elevation in serum BAFF significantly related to gastrointestinal track involvement and methotrexate therapy.



Methods

    • This is a case-control study in which patients with the established diagnosis of SSc were recruited.
    • The diagnosis of SSc was established according to the American Rheumatology Association 1980 criteria for the classification of scleroderma.
    • Patients' assessment included evaluation of skin involvement using the Modified Rodnan score and disease severity using the Medsger score.
    • Twenty-five healthy matching controls were included.
    • The sandwich enzyme-linked immunosorbent assay technique was used for direct assessment of serum BAFF in patients and controls

Results


    • The study included 60 patients (54 female and 6 male), with a mean age of 38.18±12.06 years, with mean disease duration of 7.85±4.075 years.
    • Serum BAFF in patients ranged 98.2-5015 pg/mL with mean BAFF 1100±835.4 pg/mL.
    • In controls serum BAFF levels ranged 188.5-2314 pg/mL with mean BAFF 546.1±471.1 pg/mL, showing a statistically significant elevation of serum BAFF levels in SSc patients (P=0.0001) with insignificant correlation to skin disease or total Medsgar Score of the study population (P>0.05).
    • Serum BAFF levels showed significant correlation with episodes of pseudo-obstruction and methotrexate (MTX) use in the patients studied (P<0.05)



Dr Reem Hamdy A. Mohammed (12/18/2012) comments:

It is really great and we as authors are proud of having our article selected in this great scientific citation, Mdlinx team have been also active, nonreluctant and enthausiastic in encouraging spread of scientific knowledge and anchorage of research knowledge allover

More articles in rheumatology at MDLinx.com

Bisphosphates decrease risk of stroke

  
  
  
  
  
In a study involving 2148 patients on bisphosphonate therapy and 6444 matched patients with osteoporotic fractures who were followed for 2 years, the risk of stroke was significantly reduced in the former group (8.6% vs. 10.8% [HR=.79]).  Bisphosphonate users had a 0.53- and 0.81-fold risk of subarachnoid and ischemic strokes, respectively, compared to non-users.
All Posts

Trending Medical Articles

Tuesday, Jul 15, 2014
Hypertension Research, 07/15/2014 Jong GP, et al. – The results of this study suggest that hypertensive patients who take diuretics have a significant increase in the risk of NAF, whereas patients who take ACE inhibitors are at lower risk of NAF. Methods The authors report a population–based study in which they investigated the relationship between antihypertensive drug...Read More
Tuesday, Jul 15, 2014
The American Journal of Cardiology, 07/15/2014 Shah M, et al. – This retrospective analyses found that digoxin use was associated with a greater risk for all–cause mortality in patients aged ≥65 years with atrial fibrillation (AF) regardless of concomitant heart failure (HF). Large, multicenter, randomized controlled trials or prospective cohort studies are required to clarify...Read More
Tuesday, Jul 8, 2014
Urology, 07/08/2014 Bosch PC– In this study, authors want to examine the significant “placebo effect” in a randomized, double–blind, placebo–controlled interstitial cystitis/bladder pain syndrome trial. Patients with moderate to severe interstitial cystitis/bladder pain syndrome had significant improvement after receiving only advice and support. This intervention is risk...Read More
Monday, Jul 14, 2014
Journal of Clinical Microbiology, 07/14/2014 Deng S, et al. – The study indicate that rapid and sensitive assays are developed for the detection of Cladophialophora carrionii, a common agent of human chromoblastomycosis. Therefore, result reveal that Rolling Circle Amplification (RCA), Multiplex Ligation-dependent Probe Amplification (MLPA) and Loop-mediated Isothermal Amplification...Read More
Wednesday, Jul 2, 2014
Tuberculosis , 07/02/2014 Biadglegne F, et al. – The authors conducted a cross–sectional study to evaluate the performance of Xpert test for direct detection of the Mycobacterium tuberculosis complex (MTBC) and rifampicin (RIF) resistance in lymph node aspirates. The Xpert assay was found to perform well in detecting MTBC and RIF resistance in TB lymphadenitis patients....Read More